OTLC News and Press, Oncotelic Therapeutics Inc From 04/20/21

Oncotelic Therapeutics ([[OTLC]] -4.6%) posts positive topline data from its COVID-19 clinical trial, ARTI-19, evaluating PulmoHeal against COVID-19 in India.PulmoHeal, which is being developed by Oncotelic in partnership with Windlas Biotech Private, when added to the sta...

AGOURA HILLS, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (" Oncotelic " or the "Company") (OTCQB:O TLC) , a leading developer of TGF-β therapeutics for oncology and COVID-19, reports positive top line data from its COVID-19 clinica...

Oncotelic Therapeutics ([[OTLC]] +2.0%) says that the combination therapy of anti-sense oligonucleotide targeting TGF-β2 ((TASO)) and the IL-2 Proleukin (aldesleukin) has an anti-tumor effect.The combination treatment of trabedersen and low-dose Proleukin decreased cancer cell via...

AGOURA HILLS, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (" Oncotelic " or the "Company") (OTCQB:OTLC) announced today a presentation at AACR-2021 (American Association for Cancer Research/ Annual Meeting) entitled: Combination therapy of anti-se...

AGOURA HILLS, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC) (f/k/a Mateon Therapeutics, Inc.) announced today that the Chopra Foundation and Jiva are collaborating to bring a webinar regard...

AGOURA HILLS, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC) (f/k/a Mateon Therapeutics, Inc.) announced today that the Financial Industry Regulatory Authority (" FINRA ") has confirmed ...